UBS Group’s CA Healthcare Acquisition Corp. Class A Common Stock CAHC Stock Holding History

UBS Group’s Portfolio CAHC Stock Details CAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-919	Closed	-$9K	–	10648
2021 Q2	$9K	Buy	+919	New	+$9.09K	﹤0.01%	8206

UBS Group's CAHC Position: Q3 2021 in Review

UBS Group sold out of CA Healthcare Acquisition Corp. Class A Common Stock (CAHC) in Q3 2021, closing a stake of 919 shares — an estimated $9K sold.

UBS Group first reported a position in CAHC in Q2 2021 and held it in 1 quarter. The position peaked at $9K in Q2 2021. 0 funds tracked by Wall St. Rank hold CAHC as of Q3 2021.

UBS Group reported no remaining CA Healthcare Acquisition Corp. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
UBS Group sold 919 CA Healthcare Acquisition Corp. Class A Common Stock shares in Q3 2021, an estimated $9K.
UBS Group first reported a position in CA Healthcare Acquisition Corp. Class A Common Stock in Q2 2021 and held it in 1 quarter.
UBS Group's CA Healthcare Acquisition Corp. Class A Common Stock position peaked at $9K in Q2 2021.
0 funds tracked by Wall St. Rank held CA Healthcare Acquisition Corp. Class A Common Stock as of Q3 2021.

Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.